Other Flashcards
Dx of CHF
EF
Causes of high output failure?
Secondary (cancer medicines, thiamine deficiency, anemia, hyperthyroidism)
Treat underlying cause
Harmful reflex responses of CHF?
- baroreceptor reflex (activation of SNS)
- activation of RAS/kidneys
Short term responses of SNS reflex in CHF?
Compensation to increase CO & BP
- tachycardia
- increased contractility
- increased vascular tone
Long term responses of SNS reflex in CHF?
- increased after load
- decreased contractility
- decreased CO
Affects of SNS & RAS in CHF
- arterial vasoconstriction (decreased CO)
- cardiac remodeling
- ventricular wall thinning/fibrosis
- reduced CO/increased circulatory congestion
Life prolonging treatment goal? Other options?
suppress compensatory mechanisms
increase contractility
Life prolonging drugs?
vasodilators: ACEI, ARBs, hydralazine, isosorbide dinitrate
aldosterone antagonists: spironolactone & eplerenone
beta blockers: carvedilol, bisoprolol, metoprolol
Positive ionotropes?
- digoxin
- phosphodiesterase inhibitor
- adrenoceptor agonist
MOA of digoxin?
- increase Ca
- shortens AP/increases contractility
- slow conduction thru AV node
Digoxin has a ____ therapeutic window.
Narrow; can get toxic effects easily
arrhythmic ADR of digoxin
- bigeminy (two contractions for one SA node impulse)
- ventricular tachycardia
- fibrillation
- death
- worsens WPW
- any arrhythmia
GI ADR of digoxin
earliest signs of toxicity anorexia nausea vomiting diarrhea
CNS ADRs of digoxin
hallucinations
disorientation
visual changes (yellow & green)
Other ADRs of digoxin
gynecomastia
seizures (severe)
Potassium & digoxin
want K on high side of normal to prevent arrhythmias
check frequently
Ca & digoxin
want on low side of normal to prevent arrhythmias
Mg & digoxin
want on low side of normal to prevent arrhythmias
Tx for toxicity of digoxin
GI: lower dose
Arrhythmias: check K, Mg, Ca, digoxin levels, & EKG
… severe give monoclonal antibodies (Digibind: binds and inactivates digoxin)
Clinical uses of Digoxin
CHF & Afib
3rd line Afib
MOA of milrinone?
inhibits PDE-3
increases Ca
increases contractility
vasodilation
ADRs of milrinone
Nausea Vomiting arrhythmias low platelets liver enzyme changes
Use of milrinone?
acute CHF, severe exacerbation of CHF
MOA of dobutamine
increases CO by stimulating B1 receptors (increases contractility)